Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review-Reference-Cited by-同舟云学术

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review

Published:2014-08-11 Issue:6 Volume:3 Page:1502-1511
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Fiteni Frédéric¹²,Nguyen Thierry¹,Vernerey Dewi²,Paillard Marie‐Justine¹,Kim Stefano¹³,Demarchi Martin¹³,Fein Francine⁴,Borg Christophe¹⁵,Bonnetain Franck²⁶,Pivot Xavier¹⁵

Affiliation:

1. Department of Medical Oncology University Hospital of Besançon Besançon France

2. Methodology and Quality of Life in Oncology Unit University Hospital of Besançon Besançon France

3. Department of Medical Oncology Hospital of Montbéliard Montbéliard France

4. Department of Gastroenterology University Hospital of Besançon Besançon France

5. INSERM, Unit 1098 University of Franche‐Comté Besançon France

6. EA 3181 University of Franche‐Comté Besançon France

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.299

Reference40 articles.

1. Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the “Cholangiocarcinoma” committee of the Italian Association for the Study of Liver disease

2. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

3. Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

4. Mitomycin C in combination with capecitabine or biweeklyhigh-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial

5. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world treatment patterns and challenges of patients with biliary tract cancer: retrospective chart review survey in Europe (GARNET-2);ESMO Real World Data and Digital Oncology;2024-09

2. Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer;European Journal of Cancer;2024-08

3. Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case;Frontiers in Oncology;2024-07-15

4. Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF);Liver International;2024-07-05

5. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT);European Journal of Cancer;2024-05